286 related articles for article (PubMed ID: 25563319)
1. Prognostic factors predicting the postoperative survival period following treatment for primary retroperitoneal liposarcoma.
Zhao X; Li P; Huang X; Chen L; Liu N; She Y
Chin Med J (Engl); 2015 Jan; 128(1):85-90. PubMed ID: 25563319
[TBL] [Abstract][Full Text] [Related]
2. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
Singer S; Antonescu CR; Riedel E; Brennan MF
Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
[TBL] [Abstract][Full Text] [Related]
4. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
[TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.
Bautista N; Su W; O'Connell TX
Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of prognostic factors for liposarcoma].
Zhang Q; Li JM; Liu JL; Wei YZ
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):943-948. PubMed ID: 31874553
[No Abstract] [Full Text] [Related]
7. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma.
Molina G; Hull MA; Chen YL; DeLaney TF; De Amorim Bernstein K; Choy E; Cote G; Harmon DC; Mullen JT; Haynes AB
J Surg Oncol; 2016 Dec; 114(7):814-820. PubMed ID: 27634478
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
Erzen D; Sencar M; Novak J
J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
[TBL] [Abstract][Full Text] [Related]
9. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.
Park JO; Qin LX; Prete FP; Antonescu C; Brennan MF; Singer S
Ann Surg; 2009 Dec; 250(6):977-82. PubMed ID: 19953716
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for recurrence and survival in patients with primary retroperitoneal tumors.
Li B; Luo CH; Zheng W
J BUON; 2013; 18(3):782-7. PubMed ID: 24065499
[TBL] [Abstract][Full Text] [Related]
11. [Unique massive recurrence liposarcoma of the retroperitoneum].
Wiewióra M; Pardela M; Kobielski A
Wiad Lek; 2006; 59(7-8):577-9. PubMed ID: 17209365
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of aggressive surgical treatment of primary and recurrent retroperitoneal liposarcomas.
Marinello P; Montresor E; Iacono C; Bortolasi L; Acerbi A; Facci E; Martignoni G; Brunelli M; Mainente M; Serio G
Chir Ital; 2001; 53(2):149-57. PubMed ID: 11396061
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors predicting postoperative survival period in the treatment of primary retroperitoneal leiomyosarcoma].
Zhao XD; Li PY; Huang XH; Chen L; Li R; Liu N
Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):891-4. PubMed ID: 24433766
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.
Abdelfatah E; Guzzetta AA; Nagarajan N; Wolfgang CL; Pawlik TM; Choti MA; Schulick R; Montgomery EA; Meyer C; Thornton K; Herman J; Terezakis S; Frassica D; Ahuja N
J Surg Oncol; 2016 Jul; 114(1):56-64. PubMed ID: 27076350
[TBL] [Abstract][Full Text] [Related]
16. Management of high-grade retroperitoneal liposarcomas: personal experience.
Milone M; Pezzullo LS; Salvatore G; Pezzullo MG; Leongito M; Esposito I; Milone F
Updates Surg; 2011 Jun; 63(2):119-24. PubMed ID: 21455814
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of influence factors for short-term recurrence of retroperitoneal liposarcoma after complete resection].
Deng H; Cui H; Cao B; Liu GB; Song LQ; Li HH; Zhao RY; Chen L; Wei B
Zhonghua Wai Ke Za Zhi; 2022 Jan; 60(1):52-56. PubMed ID: 34954947
[No Abstract] [Full Text] [Related]
18. Demographics, management and treatment outcomes of benign and malignant retroperitoneal tumors in Japan.
Fujimoto N; Kubo T; Hisaoka M; Udo K; Yokomizo A; Shibuya T; Wakeda H; Nishihara K; Moriya R; Iwakuma K;
Int J Urol; 2018 Jan; 25(1):61-67. PubMed ID: 28994196
[TBL] [Abstract][Full Text] [Related]
19. [Results of surgical therapy of primary and recurrent retroperitoneal liposarcoma].
Hiller WF; Jähne J; Tusch G; Meyer HJ; Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():234-6. PubMed ID: 9101841
[TBL] [Abstract][Full Text] [Related]
20. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
